Literature DB >> 23701643

Revised stereochemistry of ceramide-trafficking inhibitor HPA-12 by X-ray crystallography analysis.

Masaharu Ueno1, Yi-Yong Huang, Akihito Yamano, Shū Kobayashi.   

Abstract

In response to Berkeš's report revising the stereochemistry of HPA-12, an important ceramide-trafficking inhibitor that was discovered and synthesized and its stereochemistry determined in 2001, the synthesis and the stereochemistry were reinvestigated. A large-scale synthetic method for HPA-12 based on a Zn-catalyzed asymmetric Mannich-type reaction in water was developed. Single crystals of HPA-12 for X-ray crystallographic analysis were obtained from ethyl propionate/n-hexane, and the stereochemistry was definitely determined to be 1R,3S, consistent with Berkeš's revised structure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23701643     DOI: 10.1021/ol401101u

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Synthesis of anti-1,3 Amino Alcohol Motifs via Pd(II)/SOX Catalysis with the Capacity for Stereodivergence.

Authors:  Rulin Ma; Jonathon Young; Rossella Promontorio; Friederike M Dannheim; Christopher C Pattillo; M Christina White
Journal:  J Am Chem Soc       Date:  2019-06-05       Impact factor: 15.419

2.  ABCB4 exports phosphatidylcholine in a sphingomyelin-dependent manner.

Authors:  Yu Zhao; Masato Ishigami; Kohjiro Nagao; Kentaro Hanada; Nozomu Kono; Hiroyuki Arai; Michinori Matsuo; Noriyuki Kioka; Kazumitsu Ueda
Journal:  J Lipid Res       Date:  2015-01-19       Impact factor: 5.922

3.  Intellectual disability-associated gain-of-function mutations in CERT1 that encodes the ceramide transport protein CERT.

Authors:  Hiroaki Murakami; Norito Tamura; Yumi Enomoto; Kentaro Shimasaki; Kenji Kurosawa; Kentaro Hanada
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

Review 4.  Natural Ligand-Mimetic and Nonmimetic Inhibitors of the Ceramide Transport Protein CERT.

Authors:  Kentaro Hanada; Shota Sakai; Keigo Kumagai
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.